Unlock instant, AI-driven research and patent intelligence for your innovation.

Compounds for inhibiting insulin secretion and methods related thereto

a technology of compound and insulin, applied in the field of compound, can solve the problems of hyperglycemia and/or excessive weight gain, none of the current pharmacological therapies correct the underlying biochemical defect, and all currently available treatments improve. , to achieve the effect of enhancing insulin secretion

Inactive Publication Date: 2006-01-05
MITHOKO
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The patent is about compounds that can help treat diabetes by improving insulin secretion. These compounds can be used to treat both type 2 diabetes and maturity onset diabetes of the young. They work by enhancing the function of a protein called the mitochondrial calcium / sodium antiporter, which is involved in insulin secretion. The compounds can be administered alone or in combination with other drugs that lower blood glucose levels. Overall, this invention provides a new way to develop drugs for diabetes treatment."

Problems solved by technology

Consequently, undesirable chronic hyperinsulinemia, hypoglycemia and / or excessive weight gain may result following treatment with such drugs (Cobb et al., 1998 Ann. Rep. Med. Chem.
None of the current pharmacological therapies corrects the underlying biochemical defect in type 2 DM.
Neither do any of these currently available treatments improve all of the physiological abnormalities in type 2 DM such as impaired insulin secretion, insulin resistance and / or excessive hepatic glucose output.
In addition, treatment failures are common with these agents, such that multi-drug therapy is frequently necessary.
These processes require the maintenance of a mitochondrial membrane electrochemical potential, and defects in such membrane potential can result in a variety of disorders.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds for inhibiting insulin secretion and methods related thereto
  • Compounds for inhibiting insulin secretion and methods related thereto
  • Compounds for inhibiting insulin secretion and methods related thereto

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0103]

Synthesis of 4-chloro-1′,1′,1′-trimethylacetanilide (2a)

[0104] To a solution of 4-chloroaniline (1a) (20 g, 0.157 mole) in DCM (400 ml) at 0° C. was added DIEA (54.7 ml, 0.314 mol) and pivaloyl chloride (23.2 ml, 0.188 mol). The mixture was stirred for 2 hours and washed with water (500 ml×2), 10% NaHCO3 (aq.) (500 ml×2), water (500 ml×2) and dried over Na2SO4. The crude product was recrystalized from ethyl acetate to give the title compound 2a as a white solid (23 g, 69% yield).

Synthesis of 3a (W1=5-Cl, R1=4-pyridyl)

[0105] To a solution of the 4-chloro-1′,1′,1′-trimethylacetanilide (a (509 mg, 2.4 mmol) in THF (10 ml) under an atmosphere of nitrogen cooled to −78° C. was added n-butyllithium (2.5 ml, 2.4 M solution in diethyl ether, 6 mmol) over 5 min. The reaction was left to warm up to 0° C. and kept at this temperature for 2 hrs. Pyridine-4-carboxaldehyde (515 mg, 4.8 mmol) dissolved in THF (2 ml) was added and the reaction was left to slowly warm to room temperature ov...

example 2

[0110]

Synthesis of 5a (W1=5-Cl, R2=NH2)

[0111] To a solution of N,O-dimethylhydroxylamine hydrochloride (2.0 g, 20 mmol) dissolved in 90% ethanol (40 ml) was added triethylamine (2.5 ml, 20 mmol). The reaction was left stirring for 10 min and 5-chloroisatoic anhydride (3 g, 15.2 mmol) was added to the above solution in small portions. The reaction was heated to reflux for 1 h, after which time it was poured into a 1:1 ice / saturated sodium bicarbonate solution (50 ml). The ethanol was removed under reduced pressure and the resulting aqueous solution was extracted with ethyl acetate (3×50 ml). The combined organic phase was dried over magnesium sulfate, filtered and the solvent removed in vacuum to yield a colorless oil. This material was further purified by flash chromatography on silica gel (150 g) using petroleum ether:ethyl acetate 2:1 then 1:1 as eluent, to provide the desired compound 5a as a slightly off white solid (2.61 g, 70% yield)); Rf (petroleum ether:ethyl acetate (2:1)=...

example 3

[0138]

Synthesis of 8a (W1=5-methyl)

[0139] A mixture of 2-amino-5-methylbenzoic acid (La) (2.0 g, 0.013 mol) and AR grade THF (21 ml) was cooled to 0° C. With vigorous stirring, anhydrous sodium carbonate (2.2 g, 0.021 mol, 1.6 eq.) was added followed by benzoyl chloride (3.02 ml, 0.026 mol, 2 eq.) dropwise. The mixture was left to stand at 0° C. for an additional 30 min, after which the cold bath was removed and the mixture stirred at rt overnight. Water (15 ml) was added. The reaction mixture was evaporated under reduced pressure (to remove the THF), extracted with CH2Cl2 (×2). The combined CH2Cl2 fractions were dried (Na2SO4) and evaporated under reduced pressure to give 8a as a cream colored solid (2.55 g, 82% yield). LC / MS tR=8.16 (256.1, acyclic amide), 9.47 (237.9 [M+H]+) min. The crude material was used in the next step.

Synthesis of 9a (W1=5-methyl, R1=2-methylphenyl)

[0140] A solution of the crude material 8a from the previous step (0.5 g, 2 mmol) in CH2Cl2 (15 ml) was coo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightsaaaaaaaaaa
electrochemical membrane potentialaaaaaaaaaa
concentrationaaaaaaaaaa
Login to View More

Abstract

Compounds, compositions and methods for altering insulin secretion, particularly in the context of treatment of subjects having, or suspected of being at risk for having, diabetes mellitus. The compounds have the following struture (I): including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof, wherein W1, W2, X, R1, R2, R3, R4, m and n are defined herein.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application claims the benefit of U.S. Provisional Patent Application No. 60 / 355,389 filed Feb. 8, 2002, where this provisional application is incorporated herein by reference in its entirety.TECHNICAL FIELD [0002] The invention generally relates to compounds that alter insulin secretion, as well as to composition and methods related thereto. BACKGROUND OF THE INVENTION [0003] Type 2 diabetes mellitus, or “late onset” diabetes, is a common, degenerative disease affecting 5 to 10 percent of the population in developed countries. The propensity for developing type 2 diabetes mellitus (“type 2 DM”) is reportedly maternally inherited, suggesting a mitochondrial genetic involvement. (Alcolado, J. C. and Alcolado, R., Br. Med. J. 302:1178-1180 (1991); Reny, S. L., International J. Epidem. 23:886-890 (1994)). Diabetes is a heterogeneous disorder with a strong genetic component; monozygotic twins are highly concordant and there is a high in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D213/26A61K31/44A61K31/135C07D295/18A61K31/136A61K31/16A61K31/165A61K31/166A61K31/17A61K31/18A61K31/192A61K31/216A61K31/22A61K31/223A61K31/36A61K31/381A61K31/40A61K31/415A61K31/417A61K31/4184A61K31/4245A61K31/426A61K31/428A61K31/4402A61K31/4406A61K31/4409A61K31/4439A61K31/445A61K31/495A61K31/5375A61K45/00A61P3/10A61P7/12A61P43/00C07C45/46C07C45/67C07C205/56C07C211/29C07C229/14C07C229/34C07C233/11C07C237/04C07C237/10C07C237/14C07C317/44C07C323/29C07C323/40C07C323/41C07C323/42C07C323/44C07C323/49C07C323/52C07C323/60C07C335/18C07D207/32C07D207/335C07D211/20C07D211/24C07D211/96C07D213/38C07D213/70C07D213/73C07D213/80C07D213/81C07D213/82C07D231/14C07D233/20C07D233/54C07D233/61C07D235/06C07D271/06C07D277/28C07D277/64C07D295/185C07D317/68C07D333/20C07D413/12
CPCC07C45/46C07C45/673C07D413/12C07D295/185C07D277/64C07C205/56C07C211/29C07C229/34C07C233/11C07C237/10C07C237/14C07C317/44C07C323/29C07C323/40C07C323/41C07C323/42C07C323/44C07C323/49C07C323/52C07C323/60C07C335/18C07C2101/02C07C2101/14C07D207/335C07D211/24C07D211/96C07D213/38C07D213/70C07D213/73C07D213/81C07D213/82C07D231/14C07D233/20C07D233/64C07D271/06C07D277/28C07C49/83C07C2601/02C07C2601/14A61P43/00A61P7/12A61P3/10
Inventor PEI, YAZHONGGHOSH, SOUMITRA S.JAMES, IAN WILLIAM
Owner MITHOKO